Cliff Asness’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.08M Sell
326,124
-13,914
-4% -$133K ﹤0.01% 2333
2026
Q1
$3.1M Sell
340,038
-106,719
-24% -$895K ﹤0.01% 2067
2025
Q4
$3.32M Buy
446,757
+56,530
+14% +$406K ﹤0.01% 1819
2025
Q3
$2.61M Buy
390,227
+972
+0.2% +$6.75K ﹤0.01% 1817
2025
Q2
$2.58M Buy
389,255
+101,683
+35% +$721K ﹤0.01% 1634
2025
Q1
$2.63M Sell
287,572
-63,589
-18% -$635K ﹤0.01% 1465
2024
Q4
$3.69M Sell
351,161
-15,539
-4% -$184K ﹤0.01% 1230
2024
Q3
$4.38M Buy
+366,700
New +$3.17M 0.01% 1122
2023
Q2
Sell
-86,147
Closed -$92.2K 2198
2023
Q1
$92.2K Sell
86,147
-18,324
-18% -$35.1K ﹤0.01% 2120
2022
Q4
$273K Buy
+104,471
New +$456K ﹤0.01% 2001

Other funds holding BVS

Cliff Asness's BVS Position: Q2 2026 in Review

Cliff Asness reduced its Bioventus (BVS) stake by 4.1% in Q2 2026, selling an estimated $133K and leaving 326,124 shares worth $3.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2333.

Cliff Asness first reported a position in BVS in Q4 2022 and has held it in 10 quarters since. The position peaked at $4.38M in Q3 2024. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Cliff Asness held 326,124 shares of Bioventus worth $3.08M as of Q2 2026.
  • Cliff Asness sold 13,914 Bioventus shares in Q2 2026, an estimated $133K.
  • Bioventus made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2333 holding.
  • Cliff Asness first reported a position in Bioventus in Q4 2022 and has held it in 10 quarters since.
  • Cliff Asness's Bioventus position peaked at $4.38M in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.